Skip to main content
. 2018 Oct;10(10):5804–5812. doi: 10.21037/jtd.2018.09.118

Table 3. Parameters including pulmonary function, arterial blood gas and sleep study of all participants.

Variable CTEPH without OSA (n=25) CTEPH with OSA (n=32) P value
Pulmonary function (% pred)
   FEV1 76.95±13.09 73.92 ±14.55 0.671
   FVC 84.00±11.07 84.38±16.06 0.786
   FEV1/FVC 95.81±8.61 92.50±9.14 0.431
   TLC 81.67±7.78 79.38±13.05 0.618
   DLCO 68.57±14.54 67.96±9.46 0.943
Arterial blood gas
   PaO2 (mmHg) 68.22±13.27 60.13±13.48 0.008
   PaCO2 (mmHg) 36.78±5.27 34.45±4.79 0.104
   SPO2 (%) 93.26±2.25 90.32±4.16 0.004
Sleep study
   AHI 2.43 (0.85–4.20) 16.74 (7.65–23.65) <0.001
   ODI 3.50 (1.75–6.05) 13.35 (8.40–31.45) <0.001
   SPO2-min (%) 80.28±8.75 77.25±7.82 0.041
   SPO2 <90% (%) 43.15±33.08 49.20±32.88 0.495

Data are presented as mean ± SD or median (interquartile range). CTEPH, chronic thromboembolic pulmonary hypertension; OSA, obstructive sleep apnea; FEV1, forced expiratory volume at first second; FVC, forced vital capacity; TLC, total lung capacity; DLCO, diffusion capacity for carbon monoxide of the lung; PaO2, partial pressure of oxygen; PaCO2, partial pressure of carbon dioxide; SPO2, oxygen saturation; AHI, apnea-hypopnea index; ODI, oxygen desaturation index; SPO2-min, minimum oxygen saturation; SPO2 <90%, time spent lower than 90% of oxygen saturation.